Can Constellation Brands’ Entry into the Market Lead to Banking Reform?
December 2, 2017
2 Million Patients Impacted by Failure to Renew Rohrabacher-Blumenauer Amendment?
December 7, 2017Can Constellation Brands’ Entry into the Market Lead to Banking Reform?
December 2, 20172 Million Patients Impacted by Failure to Renew Rohrabacher-Blumenauer Amendment?
December 7, 2017
- An estimated 22.2 million Brazilians suffer from chronic pain in the lower back and neck.
- Were Brazil to legalize medical cannabis, within the first 36 months of sales the number of qualified patients could reach 959,000 under a restrictive list of qualifying conditions (i.e., not including chronic pain), or roughly 3.4 million under an expansive list of conditions (covering chronic pain).
- An expansive program featuring chronic pain as a qualifying condition and patient counts of 3.4 million patients would translate to annual revenues of roughly BRL 4.4 billion (USD 1.4 billion).
